DOCSLIB.ORG

Mouse Haus1 Conditional Knockout Project (CRISPR/Cas9)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mouse Haus1 Conditional Knockout Project (CRISPR/Cas9) https://www.alphaknockout.com Mouse Haus1 Conditional Knockout Project (CRISPR/Cas9) Objective: To create a Haus1 conditional knockout Mouse model (C57BL/6J) by CRISPR/Cas-mediated genome engineering. Strategy summary: The Haus1 gene (NCBI Reference Sequence: NM_146089 ; Ensembl: ENSMUSG00000041840 ) is located on Mouse chromosome 18. 9 exons are identified, with the ATG start codon in exon 1 and the TGA stop codon in exon 9 (Transcript: ENSMUST00000048192). Exon 3~4 will be selected as conditional knockout region (cKO region). Deletion of this region should result in the loss of function of the Mouse Haus1 gene. To engineer the targeting vector, homologous arms and cKO region will be generated by PCR using BAC clone RP23-196O5 as template. Cas9, gRNA and targeting vector will be co-injected into fertilized eggs for cKO Mouse production. The pups will be genotyped by PCR followed by sequencing analysis. Note: Exon 3 starts from about 24.7% of the coding region. The knockout of Exon 3~4 will result in frameshift of the gene. The size of intron 2 for 5'-loxP site insertion: 2655 bp, and the size of intron 4 for 3'-loxP site insertion: 951 bp. The size of effective cKO region: ~2727 bp. The cKO region does not have any other known gene. Page 1 of 7 https://www.alphaknockout.com Overview of the Targeting Strategy Wildtype allele 5' gRNA region gRNA region 3' 1 3 4 5 6 9 Targeting vector Targeted allele Constitutive KO allele (After Cre recombination) Legends Exon of mouse Haus1 Homology arm cKO region loxP site Page 2 of 7 https://www.alphaknockout.com Overview of the Dot Plot Window size: 10 bp Forward Reverse Complement Sequence 12 Note: The sequence of homologous arms and cKO region is aligned with itself to determine if there are tandem repeats. No significant tandem repeat is found in the dot plot matrix. So this region is suitable for PCR screening or sequencing analysis. Overview of the GC Content Distribution Window size: 300 bp Sequence 12 Summary: Full Length(9227bp) | A(26.3% 2427) | C(21.76% 2008) | T(28.64% 2643) | G(23.29% 2149) Note: The sequence of homologous arms and cKO region is analyzed to determine the GC content. No significant high GC-content region is found. So this region is suitable for PCR screening or sequencing analysis. Page 3 of 7 https://www.alphaknockout.com BLAT Search Results (up) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr18 - 77764459 77767458 3000 browser details YourSeq 213 1826 2569 3000 90.2% chr1 + 78213654 78530734 317081 browser details YourSeq 180 2220 2566 3000 83.2% chr2 - 54193617 54193868 252 browser details YourSeq 173 2228 2569 3000 82.1% chr3 + 59046504 59046765 262 browser details YourSeq 171 2263 2762 3000 91.0% chr16 + 94494447 94495237 791 browser details YourSeq 166 2264 2569 3000 92.4% chr3 - 94743832 94744253 422 browser details YourSeq 165 2228 2571 3000 90.3% chr4 + 137822537 137823182 646 browser details YourSeq 163 2362 2739 3000 84.5% chrX - 56603899 56604244 346 browser details YourSeq 162 2366 2569 3000 91.4% chr12 - 20210422 20210629 208 browser details YourSeq 162 2220 2568 3000 84.6% chr11 - 70673058 70673364 307 browser details YourSeq 160 2363 2569 3000 91.0% chr15 - 78818854 78819381 528 browser details YourSeq 160 2366 2569 3000 90.9% chr12 + 23954914 23955120 207 browser details YourSeq 159 2257 2569 3000 83.3% chr16 - 31911629 31911868 240 browser details YourSeq 159 2366 2569 3000 90.8% chr12 - 18833213 18833418 206 browser details YourSeq 159 2366 2569 3000 90.8% chr12 + 22893762 22893967 206 browser details YourSeq 158 2387 2591 3000 88.5% chr19 + 11746878 11747076 199 browser details YourSeq 158 2363 2571 3000 89.2% chr1 + 52635599 52635816 218 browser details YourSeq 156 2379 2571 3000 93.5% chr8 + 84007066 84007261 196 browser details YourSeq 156 1807 2570 3000 78.9% chr17 + 26252235 26252646 412 browser details YourSeq 155 2387 2569 3000 93.9% chr17 - 28530362 28530548 187 Note: The 3000 bp section upstream of Exon 3 is BLAT searched against the genome. No significant similarity is found. BLAT Search Results (down) QUERY SCORE START END QSIZE IDENTITY CHROM STRAND START END SPAN ----------------------------------------------------------------------------------------------- browser details YourSeq 3000 1 3000 3000 100.0% chr18 - 77758732 77761731 3000 browser details YourSeq 520 310 2872 3000 91.7% chr4 - 116048930 116529546 480617 browser details YourSeq 147 310 482 3000 94.1% chr10 - 128436791 128436980 190 browser details YourSeq 147 305 482 3000 93.1% chr1 + 60035479 60035675 197 browser details YourSeq 143 310 486 3000 93.4% chr3 - 145849796 145849986 191 browser details YourSeq 140 295 478 3000 91.3% chr17 + 42824127 42824314 188 browser details YourSeq 139 295 469 3000 93.3% chr5 - 24643413 24643610 198 browser details YourSeq 137 2774 3000 3000 85.9% chr5 + 149393340 149393583 244 browser details YourSeq 136 310 483 3000 93.6% chr11 - 33165433 33165620 188 browser details YourSeq 136 310 469 3000 94.9% chr17 + 74934284 74934465 182 browser details YourSeq 134 311 482 3000 92.0% chr7 + 107707328 107707513 186 browser details YourSeq 132 1439 1579 3000 97.2% chr4 - 98872451 98872592 142 browser details YourSeq 131 310 463 3000 94.0% chr17 + 69313279 69313448 170 browser details YourSeq 130 1439 1582 3000 95.2% chr17 - 44590969 44591112 144 browser details YourSeq 129 310 463 3000 93.4% chr12 - 65024616 65024785 170 browser details YourSeq 126 310 469 3000 92.2% chr6 + 85972011 85972193 183 browser details YourSeq 124 1768 1980 3000 87.5% chr5 - 127581667 127582184 518 browser details YourSeq 123 2768 2991 3000 86.0% chr13 - 95198740 95198981 242 browser details YourSeq 123 310 463 3000 91.4% chr11 + 60725674 60725843 170 browser details YourSeq 117 2759 2962 3000 84.5% chr5 + 64928030 64928235 206 Note: The 3000 bp section downstream of Exon 4 is BLAT searched against the genome. No significant similarity is found. Page 4 of 7 https://www.alphaknockout.com Gene and protein information: Haus1 HAUS augmin-like complex, subunit 1 [ Mus musculus (house mouse) ] Gene ID: 225745, updated on 24-Oct-2019 Gene summary Official Symbol Haus1 provided by MGI Official Full Name HAUS augmin-like complex, subunit 1 provided by MGI Primary source MGI:MGI:2385076 See related Ensembl:ENSMUSG00000041840 Gene type protein coding RefSeq status VALIDATED Organism Mus musculus Lineage Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; Murinae; Mus; Mus Also known as Ccdc5; HEI-C; BC024400 Expression Broad expression in CNS E11.5 (RPKM 6.2), testis adult (RPKM 5.4) and 19 other tissues See more Orthologs human all Genomic context Location: 18; 18 E3 See Haus1 in Genome Data Viewer Exon count: 15 Annotation release Status Assembly Chr Location 108 current GRCm38.p6 (GCF_000001635.26) 18 NC_000084.6 (77757277..77773885, complement) Build 37.2 previous assembly MGSCv37 (GCF_000001635.18) 18 NC_000084.5 (77996306..78006519, complement) Chromosome 18 - NC_000084.6 Page 5 of 7 https://www.alphaknockout.com Transcript information: This gene has 3 transcripts Gene: Haus1 ENSMUSG00000041840 Description HAUS augmin-like complex, subunit 1 [Source:MGI Symbol;Acc:MGI:2385076] Gene Synonyms Ccdc5, HEI-C, spindle associated Location Chromosome 18: 77,757,567-77,773,886 reverse strand. GRCm38:CM001011.2 View alleles of this gene on alternative sequences About this gene This gene has 3 transcripts (splice variants), 1 gene allele, 208 orthologues and is a member of 1 Ensembl protein family. Transcripts Name Transcript ID bp Protein Translation ID Biotype CCDS UniProt Flags Haus1-201 ENSMUST00000048192.8 1003 278aa ENSMUSP00000035826.7 Protein coding CCDS29357 Q8BHX1 TSL:1 GENCODE basic APPRIS P1 Haus1-202 ENSMUST00000236234.1 1226 293aa ENSMUSP00000158336.1 Protein coding - A0A494BB26 GENCODE basic Haus1-203 ENSMUST00000236575.1 6882 No protein - Retained intron - - - 36.32 kb Forward strand 77.75Mb 77.76Mb 77.77Mb 77.78Mb Genes Atp5a1-201 >protein coding (Comprehensive set... Atp5a1-202 >protein coding Atp5a1-204 >nonsense mediated decay Atp5a1-203 >retained intron Atp5a1-205 >retained intron Contigs < AC102195.14 < AC162291.13 Genes (Comprehensive set... < Haus1-202protein coding < Haus1-201protein coding < Haus1-203retained intron Regulatory Build 77.75Mb 77.76Mb 77.77Mb 77.78Mb Reverse strand 36.32 kb Regulation Legend CTCF Enhancer Promoter Promoter Flank Transcription Factor Binding Site Gene Legend Protein Coding Ensembl protein coding merged Ensembl/Havana Non-Protein Coding processed transcript Page 6 of 7 https://www.alphaknockout.com Transcript: ENSMUST00000048192 < Haus1-201protein coding Reverse strand 10.21 kb ENSMUSP00000035... Low complexity (Seg) Coiled-coils (Ncoils) Prints HAUS augmin-like complex subunit 1 PANTHER HAUS augmin-like complex subunit 1 All sequence SNPs/i... Sequence variants (dbSNP and all other sources) Variant Legend missense variant splice region variant synonymous variant Scale bar 0 40 80 120 160 200 278 We wish to acknowledge the following valuable scientific information resources: Ensembl, MGI, NCBI, UCSC. Page 7 of 7.
Load more

Recommended publications
  • Entrez Symbols Name Termid Termdesc 117553 Uba3,Ube1c
    Entrez Symbols Name TermID TermDesc 117553 Uba3,Ube1c ubiquitin-like modifier activating enzyme 3 GO:0016881 acid-amino acid ligase activity 299002 G2e3,RGD1310263 G2/M-phase specific E3 ubiquitin ligase GO:0016881 acid-amino acid ligase activity 303614 RGD1310067,Smurf2 SMAD specific E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 308669 Herc2 hect domain and RLD 2 GO:0016881 acid-amino acid ligase activity 309331 Uhrf2 ubiquitin-like with PHD and ring finger domains 2 GO:0016881 acid-amino acid ligase activity 316395 Hecw2 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2 GO:0016881 acid-amino acid ligase activity 361866 Hace1 HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1 GO:0016881 acid-amino acid ligase activity 117029 Ccr5,Ckr5,Cmkbr5 chemokine (C-C motif) receptor 5 GO:0003779 actin binding 117538 Waspip,Wip,Wipf1 WAS/WASL interacting protein family, member 1 GO:0003779 actin binding 117557 TM30nm,Tpm3,Tpm5 tropomyosin 3, gamma GO:0003779 actin binding 24779 MGC93554,Slc4a1 solute carrier family 4 (anion exchanger), member 1 GO:0003779 actin binding 24851 Alpha-tm,Tma2,Tmsa,Tpm1 tropomyosin 1, alpha GO:0003779 actin binding 25132 Myo5b,Myr6 myosin Vb GO:0003779 actin binding 25152 Map1a,Mtap1a microtubule-associated protein 1A GO:0003779 actin binding 25230 Add3 adducin 3 (gamma) GO:0003779 actin binding 25386 AQP-2,Aqp2,MGC156502,aquaporin-2aquaporin 2 (collecting duct) GO:0003779 actin binding 25484 MYR5,Myo1e,Myr3 myosin IE GO:0003779 actin binding 25576 14-3-3e1,MGC93547,Ywhah
    [Show full text]
  • Supp Material.Pdf
    Simon et al. Supplementary information: Table of contents p.1 Supplementary material and methods p.2-4 • PoIy(I)-poly(C) Treatment • Flow Cytometry and Immunohistochemistry • Western Blotting • Quantitative RT-PCR • Fluorescence In Situ Hybridization • RNA-Seq • Exome capture • Sequencing Supplementary Figures and Tables Suppl. items Description pages Figure 1 Inactivation of Ezh2 affects normal thymocyte development 5 Figure 2 Ezh2 mouse leukemias express cell surface T cell receptor 6 Figure 3 Expression of EZH2 and Hox genes in T-ALL 7 Figure 4 Additional mutation et deletion of chromatin modifiers in T-ALL 8 Figure 5 PRC2 expression and activity in human lymphoproliferative disease 9 Figure 6 PRC2 regulatory network (String analysis) 10 Table 1 Primers and probes for detection of PRC2 genes 11 Table 2 Patient and T-ALL characteristics 12 Table 3 Statistics of RNA and DNA sequencing 13 Table 4 Mutations found in human T-ALLs (see Fig. 3D and Suppl. Fig. 4) 14 Table 5 SNP populations in analyzed human T-ALL samples 15 Table 6 List of altered genes in T-ALL for DAVID analysis 20 Table 7 List of David functional clusters 31 Table 8 List of acquired SNP tested in normal non leukemic DNA 32 1 Simon et al. Supplementary Material and Methods PoIy(I)-poly(C) Treatment. pIpC (GE Healthcare Lifesciences) was dissolved in endotoxin-free D-PBS (Gibco) at a concentration of 2 mg/ml. Mice received four consecutive injections of 150 μg pIpC every other day. The day of the last pIpC injection was designated as day 0 of experiment.
    [Show full text]
  • Literature Mining Sustains and Enhances Knowledge Discovery from Omic Studies
    LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES by Rick Matthew Jordan B.S. Biology, University of Pittsburgh, 1996 M.S. Molecular Biology/Biotechnology, East Carolina University, 2001 M.S. Biomedical Informatics, University of Pittsburgh, 2005 Submitted to the Graduate Faculty of School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Pittsburgh 2016 UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE This dissertation was presented by Rick Matthew Jordan It was defended on December 2, 2015 and approved by Shyam Visweswaran, M.D., Ph.D., Associate Professor Rebecca Jacobson, M.D., M.S., Professor Songjian Lu, Ph.D., Assistant Professor Dissertation Advisor: Vanathi Gopalakrishnan, Ph.D., Associate Professor ii Copyright © by Rick Matthew Jordan 2016 iii LITERATURE MINING SUSTAINS AND ENHANCES KNOWLEDGE DISCOVERY FROM OMIC STUDIES Rick Matthew Jordan, M.S. University of Pittsburgh, 2016 Genomic, proteomic and other experimentally generated data from studies of biological systems aiming to discover disease biomarkers are currently analyzed without sufficient supporting evidence from the literature due to complexities associated with automated processing. Extracting prior knowledge about markers associated with biological sample types and disease states from the literature is tedious, and little research has been performed to understand how to use this knowledge to inform the generation of classification models from ‘omic’ data. Using pathway analysis methods to better understand the underlying biology of complex diseases such as breast and lung cancers is state-of-the-art. However, the problem of how to combine literature- mining evidence with pathway analysis evidence is an open problem in biomedical informatics research.
    [Show full text]
  • Plasma Cells in Vitro Generation of Long-Lived Human
    Downloaded from http://www.jimmunol.org/ by guest on September 24, 2021 is online at: average * The Journal of Immunology , 32 of which you can access for free at: 2012; 189:5773-5785; Prepublished online 16 from submission to initial decision 4 weeks from acceptance to publication November 2012; doi: 10.4049/jimmunol.1103720 http://www.jimmunol.org/content/189/12/5773 In Vitro Generation of Long-lived Human Plasma Cells Mario Cocco, Sophie Stephenson, Matthew A. Care, Darren Newton, Nicholas A. Barnes, Adam Davison, Andy Rawstron, David R. Westhead, Gina M. Doody and Reuben M. Tooze J Immunol cites 65 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription http://www.jimmunol.org/content/suppl/2012/11/16/jimmunol.110372 0.DC1 This article http://www.jimmunol.org/content/189/12/5773.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2012 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 24, 2021. The Journal of Immunology In Vitro Generation of Long-lived Human Plasma Cells Mario Cocco,*,1 Sophie Stephenson,*,1 Matthew A.
    [Show full text]
  • Investigation of Differentially Expressed Genes in Nasopharyngeal Carcinoma by Integrated Bioinformatics Analysis
    916 ONCOLOGY LETTERS 18: 916-926, 2019 Investigation of differentially expressed genes in nasopharyngeal carcinoma by integrated bioinformatics analysis ZhENNING ZOU1*, SIYUAN GAN1*, ShUGUANG LIU2, RUjIA LI1 and jIAN hUANG1 1Department of Pathology, Guangdong Medical University, Zhanjiang, Guangdong 524023; 2Department of Pathology, The Eighth Affiliated hospital of Sun Yat‑sen University, Shenzhen, Guangdong 518033, P.R. China Received October 9, 2018; Accepted April 10, 2019 DOI: 10.3892/ol.2019.10382 Abstract. Nasopharyngeal carcinoma (NPC) is a common topoisomerase 2α and TPX2 microtubule nucleation factor), malignancy of the head and neck. The aim of the present study 8 modules, and 14 TFs were identified. Modules analysis was to conduct an integrated bioinformatics analysis of differ- revealed that cyclin-dependent kinase 1 and exportin 1 were entially expressed genes (DEGs) and to explore the molecular involved in the pathway of Epstein‑Barr virus infection. In mechanisms of NPC. Two profiling datasets, GSE12452 and summary, the hub genes, key modules and TFs identified in GSE34573, were downloaded from the Gene Expression this study may promote our understanding of the pathogenesis Omnibus database and included 44 NPC specimens and of NPC and require further in-depth investigation. 13 normal nasopharyngeal tissues. R software was used to identify the DEGs between NPC and normal nasopharyngeal Introduction tissues. Distributions of DEGs in chromosomes were explored based on the annotation file and the CYTOBAND database Nasopharyngeal carcinoma (NPC) is a common malignancy of DAVID. Gene ontology (GO) and Kyoto Encyclopedia of occurring in the head and neck. It is prevalent in the eastern Genes and Genomes (KEGG) pathway enrichment analysis and southeastern parts of Asia, especially in southern China, were applied.
    [Show full text]
  • Identification of Differential Expression of P53 Associated Rnas at 3 Different Treatment Timepoints, and Association with Chip- Seq Identified P53 Genes
    Rochester Institute of Technology RIT Scholar Works Theses 5-19-2017 Identification of Differential Expression of p53 associated RNAs at 3 Different Treatment Timepoints, and Association with ChIP- seq Identified p53 Genes. Julia Freewoman [email protected] Follow this and additional works at: https://scholarworks.rit.edu/theses Recommended Citation Freewoman, Julia, "Identification of Differential Expression of p53 associated RNAs at 3 Different Treatment Timepoints, and Association with ChIP-seq Identified p53 Genes." (2017). Thesis. Rochester Institute of Technology. Accessed from This Thesis is brought to you for free and open access by RIT Scholar Works. It has been accepted for inclusion in Theses by an authorized administrator of RIT Scholar Works. For more information, please contact [email protected]. R.I.T. Identification of Differential Expression of p53 associated RNAs at 3 Different Treatment Timepoints, and Association with ChIP-seq Identified p53 Genes. by Julia Freewoman A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science in Bioinformatics. School of Thomas H. Gosnell School of Life Sciences Bioinformatics Program College of Science Rochester Institute of Technology Rochester, NY May 19, 2017 Thesis Committee Members: Feng Cui, Ph.D., thesis advisor Andre Hudson, Ph.D. Gary R. Skuse, Ph.D. ii Table of Contents Abstract ........................................................................................................................................... 1 I. Introduction
    [Show full text]
  • Identification of Genes Associated with Castration‑Resistant Prostate Cancer by Gene Expression Profile Analysis
    MOLECULAR MEDICINE REPORTS 16: 6803-6813, 2017 Identification of genes associated with castration‑resistant prostate cancer by gene expression profile analysis CHUI GUO HUANG1, FENG XI LI2, SONG PAN3, CHANG BAO XU1, JUN QIANG DAI4 and XING HUA ZHAO1 1Department of Urology, The Second Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450014; 2Department of Gastrointestinal Glands Surgery, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530000; 3Department of Urology, The First Affiliated Hospital, Zhengzhou University, Zhengzhou, Henan 450014; 4Department of Neurosurgery, The Second Affiliated Hospital, Lanzhou University, Lanzhou, Gansu 730030, P.R. China Received December 16, 2016; Accepted July 17, 2017 DOI: 10.3892/mmr.2017.7488 Abstract. Prostate cancer (CaP) is a serious and common western countries (1). CaP growth is driven by androgens; genital tumor. Generally, men with metastatic CaP can easily therefore, the conventional treatment option is to lower the develop castration-resistant prostate cancer (CRPC). However, levels of male sex hormones (2). Current treatment strate- the pathogenesis and tumorigenic pathways of CRPC remain to gies for CaP include surgery, external beam radiotherapy, be elucidated. The present study performed a comprehensive brachytherapy, chemotherapy and androgen-deprivation analysis on the gene expression profile of CRPC in order to therapy (ADT) (2,3). ADT often involves surgically determine the pathogenesis and tumorigenic of CRPC. The removing the testicles or using drugs to block the andro- GSE33316 microarray, which consisted of 5 non-castrated gens from affecting the body (4). Unfortunately, ADT has samples and 5 castrated samples, was downloaded from the gene a limited role in preventing majority of patients progressing expression omnibus database.
    [Show full text]
  • Supplemental Data.Pdf
    Supplementary material -Table of content Supplementary Figures (Fig 1- Fig 6) Supplementary Tables (1-13) Lists of genes belonging to distinct biological processes identified by GREAT analyses to be significantly enriched with UBTF1/2-bound genes Supplementary Table 14 List of the common UBTF1/2 bound genes within +/- 2kb of their TSSs in NIH3T3 and HMECs. Supplementary Table 15 List of gene identified by microarray expression analysis to be differentially regulated following UBTF1/2 knockdown by siRNA Supplementary Table 16 List of UBTF1/2 binding regions overlapping with histone genes in NIH3T3 cells Supplementary Table 17 List of UBTF1/2 binding regions overlapping with histone genes in HMEC Supplementary Table 18 Sequences of short interfering RNA oligonucleotides Supplementary Table 19 qPCR primer sequences for qChIP experiments Supplementary Table 20 qPCR primer sequences for reverse transcription-qPCR Supplementary Table 21 Sequences of primers used in CHART-PCR Supplementary Methods Supplementary Fig 1. (A) ChIP-seq analysis of UBTF1/2 and Pol I (POLR1A) binding across mouse rDNA. UBTF1/2 is enriched at the enhancer and promoter regions and along the entire transcribed portions of rDNA with little if any enrichment in the intergenic spacer (IGS), which separates the rDNA repeats. This enrichment coincides with the distribution of the largest subunit of Pol I (POLR1A) across the rDNA. All sequencing reads were mapped to the published complete sequence of the mouse rDNA repeat (Gene bank accession number: BK000964). The graph represents the frequency of ribosomal sequences enriched in UBTF1/2 and Pol I-ChIPed DNA expressed as fold change over those of input genomic DNA.
    [Show full text]
  • PDF Output of CLIC (Clustering by Inferred Co-Expression)
    PDF Output of CLIC (clustering by inferred co-expression) Dataset: Num of genes in input gene set: 7 Total number of genes: 16493 CLIC PDF output has three sections: 1) Overview of Co-Expression Modules (CEMs) Heatmap shows pairwise correlations between all genes in the input query gene set. Red lines shows the partition of input genes into CEMs, ordered by CEM strength. Each row shows one gene, and the brightness of squares indicates its correlations with other genes. Gene symbols are shown at left side and on the top of the heatmap. 2) Details of each CEM and its expansion CEM+ Top panel shows the posterior selection probability (dataset weights) for top GEO series datasets. Bottom panel shows the CEM genes (blue rows) as well as expanded CEM+ genes (green rows). Each column is one GEO series dataset, sorted by their posterior probability of being selected. The brightness of squares indicates the gene's correlations with CEM genes in the corresponding dataset. CEM+ includes genes that co-express with CEM genes in high-weight datasets, measured by LLR score. 3) Details of each GEO series dataset and its expression profile: Top panel shows the detailed information (e.g. title, summary) for the GEO series dataset. Bottom panel shows the background distribution and the expression profile for CEM genes in this dataset. Overview of Co-Expression Modules (CEMs) with Dataset Weighting Scale of average Pearson correlations Num of Genes in Query Geneset: 7. Num of CEMs: 1. 0.0 0.2 0.4 0.6 0.8 1.0 Med14 Med21 Med6 Cdk8 Ccnc Med10 Med23 Med14 Med21
    [Show full text]
  • Receptor Signaling Through Osteoclast-Associated Monocyte
    Downloaded from http://www.jimmunol.org/ by guest on September 29, 2021 is online at: average * The Journal of Immunology The Journal of Immunology , 20 of which you can access for free at: 2015; 194:3169-3179; Prepublished online 27 from submission to initial decision 4 weeks from acceptance to publication February 2015; doi: 10.4049/jimmunol.1402800 http://www.jimmunol.org/content/194/7/3169 Collagen Induces Maturation of Human Monocyte-Derived Dendritic Cells by Signaling through Osteoclast-Associated Receptor Heidi S. Schultz, Louise M. Nitze, Louise H. Zeuthen, Pernille Keller, Albrecht Gruhler, Jesper Pass, Jianhe Chen, Li Guo, Andrew J. Fleetwood, John A. Hamilton, Martin W. Berchtold and Svetlana Panina J Immunol cites 43 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Author Choice option Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://jimmunol.org/subscription Freely available online through http://www.jimmunol.org/content/suppl/2015/02/27/jimmunol.140280 0.DCSupplemental This article http://www.jimmunol.org/content/194/7/3169.full#ref-list-1 Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Author Choice Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2015 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606.
    [Show full text]
  • A Deep Proteomics Perspective on CRM1-Mediated Nuclear Export and Nucleocytoplasmic Partitioning
    A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning Koray Kırlı 1#, Samir Karaca1,2#, Heinz-Jürgen Dehne 1, Matthias Samwer 1,4, Kuan- Ting Pan 2, Christof Lenz 2,3, Henning Urlaub2,3* and Dirk Görlich1* 1 Department of Cellular Logistics and 2 Bioanalytical Mass Spectrometry Group, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany; 3 Bioanalytics, Institute for Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany. 4 Current address: Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria. # Joint first authors; *Joint corresponding authors; E-mail: [email protected]; [email protected] Abstract CRM1 is a highly conserved, RanGTPase-driven exportin that carries proteins and RNPs from the nucleus to the cytoplasm. We now explored the cargo-spectrum of CRM1 in depth and identified surprisingly large numbers, namely >700 export substrates from the yeast S. cerevisiae, ≈ 1000 from Xenopus oocytes and >1050 from human cells. In addition, we quantified the partitioning of ≈5000 unique proteins between nucleus and cytoplasm of Xenopus oocytes. The data suggest new CRM1 functions in spatial control of vesicle coat-assembly, centrosomes, autophagy, peroxisome biogenesis, cytoskeleton, ribosome maturation, translation, mRNA degradation, and more generally in precluding a potentially detrimental action of cytoplasmic pathways within the nuclear interior. There are also numerous new instances where CRM1 appears to act in regulatory circuits. Altogether, our dataset allows unprecedented insights into the nucleocytoplasmic organisation of eukaryotic cells, into the contributions of an exceedingly promiscuous exportin and it provides a new basis for NES prediction. 2 Introduction The nuclear envelope (NE) separates the cell nucleus from the cytoplasm.
    [Show full text]
  • © Ferrata Storti Foundation
    LETTERS TO THE EDITOR MO, USA), MuTect (Broad Institute, MA, USA) and A novel mechanism of NPM1 cytoplasmic localiza- Pindel (Washington University, MO, USA) plus additional tion in acute myeloid leukemia: the recurrent gene in-house criteria to reduce false positive calls. Median fusion NPM1–HAUS1 coverage of leukemia and skin sample was 70x and 30x, respectively. The search for fusion sequences was per- formed with the software Factera.8 Lentiviral vector- NPM1 heterozygous mutations are present in roughly based clones fused to fluorophores for 293T cells trans- a third of patients with acute myeloid leukemia (AML), duction were manufactured by Genecopoeia. Sanger making it one of the most frequent genomic alterations in 1 sequencing was used to confirm the fusion sequence in these patients. The mutations are characterized by both our patients. frameshift insertions in the region encoding the C-termi- Initially we studied a 63 year old woman (P1) with a nus of the protein, leading to the disruption of trypto- diagnosis of de novo AML. Bone marrow examination phan residues 288 and 290 and the generation of an addi- showed marked hypercellularity with 95% of blasts char- tional nuclear export signal (NES) motif, that ultimately acterized by medium size, intermediate nuclear:cytoplas- leads to the cytoplasmic localization of the mutated mic ratio, and the presence of nucleolus and basophilic NPM1 (NPM1m) as well as wild-type (WT) NPM1 pro- cytoplasm. See Table 1 for clinical and laboratorial char- teins.2 acteristics. The observation that patients with NPM1m AML share 1,3 Karyotype analysis was consistent with clinical, prognostic and biological features, as well as 46,XX,t(5;18)(q35;q21)[20].
    [Show full text]